Search research articles
Contact Us
Filters
Showing results (61-70 of 153) with videos related to
Page
of 16
Sort By:
Blood
|
September 5, 2015
Ceritinib in patients with advanced anaplastic lymphoma kinase-rearranged anaplastic large-cell lymphoma
Heike Richly, Tae Min Kim, Martin Schuler, et al.
Clinical & Translational Immunology
|
January 13, 2021
Successful identification of predictive profiles for infection utilising systems-level immune analysis: a pilot study in patients with relapsed and refractory multiple myeloma
Marcel Doerflinger, Alexandra L Garnham, Saskia Freytag, et al.
British Journal of Haematology
|
May 11, 2016
Marizomib irreversibly inhibits proteasome to overcome compensatory hyperactivation in multiple myeloma and solid tumour patients
Nancy Levin, Andrew Spencer, Simon J Harrison, et al.
Clinical Genitourinary Cancer
|
November 3, 2024
Chemomobilisation Using Gemcitabine-Oxaliplatin for Salvage High Dose Chemotherapy and Autologous Stem Cell Transplant in Advanced Testicular Germ Cell Cancer
Jane McKenzie, Ciara Conduit, Melissa Ng Liet Hing, et al.
Blood Advances
|
April 6, 2026
Cytomegalovirus reactivation in multiple myeloma patients receiving bispecific antibodies
Enric Sastre-Escolà, Gemma K Reynolds, Michelle K Yong, et al.
British Journal of Haematology
|
November 8, 2025
No benefit from daratumumab, bortezomib and dexamethasone (D-Vd) in real-world patients with functional high-risk multiple myeloma: A report from the Myeloma and Related Diseases Registry
Sueh-Li Lim, Cameron Wellard, Rajeev Rajagopal, et al.
Expert Review of Hematology
|
December 22, 2021
The development of a home-based therapeutic platform for multiple myeloma
Hayley Beer, David Routledge, Trish Joyce, et al.
Blood
|
October 28, 2010
The immunostimulatory effect of lenalidomide on NK-cell function is profoundly inhibited by concurrent dexamethasone therapy
Andy K Hsu, Hang Quach, Tsin Tai, et al.
Haematologica
|
January 25, 2024
Harnessing the cytotoxic granule exocytosis to augment the efficacy of T-cell-engaging bispecific antibody therapy
Mika Casey, Carol Lee, Sharon M Hoyte, et al.
Frontiers in Immunology
|
October 21, 2017
Predicting Risk of Infection in Patients with Newly Diagnosed Multiple Myeloma: Utility of Immune Profiling
Benjamin W Teh, Simon J Harrison, Cody Charles Allison, et al.
Page
of 16
Search research articles
Search
Showing results (61-70 of 153) with videos related to
Sort By:
Page
of 16
Blood
|
September 5, 2015
Ceritinib in patients with advanced anaplastic lymphoma kinase-rearranged anaplastic large-cell lymphoma
Heike Richly, Tae Min Kim, Martin Schuler, et al.
Clinical & Translational Immunology
|
January 13, 2021
Successful identification of predictive profiles for infection utilising systems-level immune analysis: a pilot study in patients with relapsed and refractory multiple myeloma
Marcel Doerflinger, Alexandra L Garnham, Saskia Freytag, et al.
British Journal of Haematology
|
May 11, 2016
Marizomib irreversibly inhibits proteasome to overcome compensatory hyperactivation in multiple myeloma and solid tumour patients
Nancy Levin, Andrew Spencer, Simon J Harrison, et al.
Clinical Genitourinary Cancer
|
November 3, 2024
Chemomobilisation Using Gemcitabine-Oxaliplatin for Salvage High Dose Chemotherapy and Autologous Stem Cell Transplant in Advanced Testicular Germ Cell Cancer
Jane McKenzie, Ciara Conduit, Melissa Ng Liet Hing, et al.
Blood Advances
|
April 6, 2026
Cytomegalovirus reactivation in multiple myeloma patients receiving bispecific antibodies
Enric Sastre-Escolà, Gemma K Reynolds, Michelle K Yong, et al.
British Journal of Haematology
|
November 8, 2025
No benefit from daratumumab, bortezomib and dexamethasone (D-Vd) in real-world patients with functional high-risk multiple myeloma: A report from the Myeloma and Related Diseases Registry
Sueh-Li Lim, Cameron Wellard, Rajeev Rajagopal, et al.
Expert Review of Hematology
|
December 22, 2021
The development of a home-based therapeutic platform for multiple myeloma
Hayley Beer, David Routledge, Trish Joyce, et al.
Blood
|
October 28, 2010
The immunostimulatory effect of lenalidomide on NK-cell function is profoundly inhibited by concurrent dexamethasone therapy
Andy K Hsu, Hang Quach, Tsin Tai, et al.
Haematologica
|
January 25, 2024
Harnessing the cytotoxic granule exocytosis to augment the efficacy of T-cell-engaging bispecific antibody therapy
Mika Casey, Carol Lee, Sharon M Hoyte, et al.
Frontiers in Immunology
|
October 21, 2017
Predicting Risk of Infection in Patients with Newly Diagnosed Multiple Myeloma: Utility of Immune Profiling
Benjamin W Teh, Simon J Harrison, Cody Charles Allison, et al.
Page
of 16